1. Home
  2. TMDX vs GOLF Comparison

TMDX vs GOLF Comparison

Compare TMDX & GOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • GOLF
  • Stock Information
  • Founded
  • TMDX 1998
  • GOLF 1910
  • Country
  • TMDX United States
  • GOLF United States
  • Employees
  • TMDX N/A
  • GOLF N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GOLF Recreational Games/Products/Toys
  • Sector
  • TMDX Health Care
  • GOLF Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • GOLF Nasdaq
  • Market Cap
  • TMDX 4.7B
  • GOLF 3.9B
  • IPO Year
  • TMDX 2019
  • GOLF 2016
  • Fundamental
  • Price
  • TMDX $88.36
  • GOLF $68.30
  • Analyst Decision
  • TMDX Buy
  • GOLF Buy
  • Analyst Count
  • TMDX 10
  • GOLF 5
  • Target Price
  • TMDX $138.20
  • GOLF $71.40
  • AVG Volume (30 Days)
  • TMDX 2.2M
  • GOLF 361.5K
  • Earning Date
  • TMDX 10-28-2024
  • GOLF 11-07-2024
  • Dividend Yield
  • TMDX N/A
  • GOLF 1.26%
  • EPS Growth
  • TMDX N/A
  • GOLF N/A
  • EPS
  • TMDX 0.94
  • GOLF 2.93
  • Revenue
  • TMDX $401,090,000.00
  • GOLF $2,424,883,000.00
  • Revenue This Year
  • TMDX $83.25
  • GOLF $5.42
  • Revenue Next Year
  • TMDX $26.27
  • GOLF $3.74
  • P/E Ratio
  • TMDX $94.29
  • GOLF $23.30
  • Revenue Growth
  • TMDX 109.09
  • GOLF 0.35
  • 52 Week Low
  • TMDX $63.86
  • GOLF $55.75
  • 52 Week High
  • TMDX $177.37
  • GOLF $76.38
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 31.88
  • GOLF 61.96
  • Support Level
  • TMDX $82.70
  • GOLF $61.85
  • Resistance Level
  • TMDX $98.88
  • GOLF $73.40
  • Average True Range (ATR)
  • TMDX 5.52
  • GOLF 2.15
  • MACD
  • TMDX 1.30
  • GOLF 1.03
  • Stochastic Oscillator
  • TMDX 15.58
  • GOLF 56.78

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About GOLF Acushnet Holdings Corp.

Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, of which key revenue is derived from the sales of golf balls and golf gloves. The operating segments of the company are Titleist golf balls, Titleist golf clubs, Titleist golf gear and FootJoy golf wear. Geographically, the company operates in the United States, EMEA, Japan, Korea and other countries, of which a majority of the revenue is generated from the operations in the United States.

Share on Social Networks: